tiprankstipranks
Outlook Therapeutics (DE:41O)
NASDAQ:41O

Compare Outlook Therapeutics (41O) vs. Competitors

7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Outlook Therapeutics
€0.22
€83.36M
-1.04
-54.26%
1 Buy
2 Hold
0 Sell
Moderate Buy
Oramed Pharm
$2.91
$155.93M
1.38
72.56%
Atara Biotherapeutics
$15.79
$92.53M
-14.75
17.81%
2 Buy
1 Hold
0 Sell
Moderate Buy
Whitehawk Therapeutics
$4.11
$217.59M
-2.48
147.02%
3 Buy
2 Hold
0 Sell
Moderate Buy
Celularity
$1.25
$28.80M
-0.24
-54.58%
Adagene
$3.97
$169.64M
-7.13
88.64%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:41O
Outlook Therapeutics
0.75
-0.87
-53.72%
ORMP
Oramed Pharm
3.71
1.63
78.54%
ATRA
Atara Biotherapeutics
9.92
0.66
7.13%
WHWK
Whitehawk Therapeutics
4.15
2.19
111.73%
CELU
Celularity
0.87
-1.11
-55.96%
ADAG
Adagene
3.32
1.41
73.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts